Health Care: Drugs

Cleveland BioLabs Inc (CBLI: NASDAQ)

$3.25 1.32 | 68.39%
05/26/15 - 04:00 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:21.4444
Price Earnings Comparisons:
CBLISector Avg.S&P 500
21.444413.727.04
Price Performance History (% change):
3 Mo1 Yr3 Yr
-47.8378-82.9806-92.4016
GROWTH12 Mo3 YrCAGR
Revenue-56.4-0.58-0.25
Net Income-1.010
EPS-1.25n/a
Earnings for CBLI:
EBITDA-14.00
REVENUE3.70M
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $n.a. $n.a. $n.a. $n.a.
Number of Analysts 0 0 0 0
High Estimate $n.a. $n.a. $n.a. $n.a.
Low Estimate $n.a. $n.a. $n.a. $n.a.
Prior Year $-0.13 $-0.12 $-0.44 $n.a.
Growth Rate (Year over Year) n.a.% n.a.% n.a.% n.a.%

Portfolios with CBLI

Latest CBLI Headlines from TheStreet

More Financial News for CBLI

Press Releases for CBLI

See All Press Releases

Partner Headlines for CBLI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter